Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Other Operating Expenses (2022 - 2025)

Gossamer Bio's Other Operating Expenses history spans 3 years, with the latest figure at -$1000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to -$1000.0; the TTM value through Dec 2025 reached $7.5 million, changed N/A, while the annual FY2025 figure was $7.5 million, N/A changed from the prior year.
  • Other Operating Expenses reached -$1000.0 in Q4 2025 per GOSS's latest filing, down from $7.5 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $10.0 million in Q4 2023 to a low of -$1000.0 in Q4 2025.
  • Average Other Operating Expenses over 3 years is $2.0 million, with a median of $15000.0 recorded in 2022.
  • The largest YoY upside for Other Operating Expenses was 66566.67% in 2023 against a maximum downside of 25.0% in 2023.
  • A 3-year view of Other Operating Expenses shows it stood at $15000.0 in 2022, then surged by 66566.67% to $10.0 million in 2023, then crashed by 100.01% to -$1000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Other Operating Expenses are -$1000.0 (Q4 2025), $7.5 million (Q3 2025), and $10.0 million (Q4 2023).